
Scientific research has shown that nicotine can improve the intelligence of patients with Alzheimer's disease.
The study was conducted by a group of American scientists led by Paul Newhouse from the Vanderbilt University School of Medicine. The core team comprised of 45 males and 29 females aged 76, whose ability to absorb and perceive new information has slightly declined. The volunteers were observed continuously for six months.
Half of the patients received nicotine patches containing 15 milligrams of nicotine daily, while the rest were given a placebo (with no nicotine). Research shows that those who received nicotine saw an improvement in their symptoms during tests for memory, mental clarity, attention, and reaction time. On the other hand, those who received the placebo saw their condition worsen.
The source of information and images on the Vanderbilt School of Medicine's official website is Vanderbilt University Medical Center.
Scientists have observed a significant reduction in the amount of nicotine receptors in the brains of individuals with Alzheimer's disease, which negatively impacts their cognitive abilities.
Statement:
This article is compiled from third-party information and is solely intended for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the truthfulness and accuracy of the content. The translation of this article is only for communication and research within the industry.
Due to limitations in the quality of translation, the compiled article may not fully reflect the original text. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any statements or positions regarding domestic, Hong Kong, Macau, Taiwan, and international affairs.
The compilation of information belongs to the original media and author, and if there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.










